Quest Diagnostics and Ultima Collaborate to Scale Ultima's Technology in Fast-Growing Minimal Residual Disease and Whole Genome SequencingBusiness Wire • 01/09/24
Quest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care SystemPRNewsWire • 01/08/24
Haystack Oncology and Alliance Foundation Trials collaborate to use Haystack MRD™ technology in phase II clinical trial for unresectable stage III NSCLCPRNewsWire • 01/08/24
Quest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test PanelPRNewsWire • 12/19/23
Haystack Oncology and Rutgers Cancer Institute Collaborate to use Haystack MRD™ in Clinical Study of Early-Stage Triple-Negative Breast CancerPRNewsWire • 12/14/23
Quest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United StatesPRNewsWire • 12/07/23
Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Seventh Consecutive YearPRNewsWire • 12/06/23
Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid ArthritisPRNewsWire • 11/28/23
Quest Diagnostics (DGX) Up 8.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/23/23
Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United StatesPRNewsWire • 11/20/23
Quest Diagnostics Launches Mobile Phlebotomy Service, Enabling Convenient At-Home Specimen Collection in the United StatesPRNewsWire • 11/09/23
Diadem SpA Announces Exclusive U.S. Licensing Agreement with Quest Diagnostics for Its AlzoSure® Predict Alzheimer's Disease Prognostic TechnologyPRNewsWire • 10/25/23